Stockreport

Bluebird Bio: Gene Therapy Best In Class [Seeking Alpha]

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF Bluebird Bio: Gene Therapy Best In ClassSummaryBluebird bio has my highest capital discipline score.Cellectis, Sangamo and Uniqure have raised over $500 million in 2Q18. [Read more]